Dexcom will make G7 15 Day CGM available through DME providers on Dec. 1
By HME News Staff
Updated 9:43 AM CST, Mon November 24, 2025
SAN DIEGO – Dexcom has announced that the Dexcom G7 15 Day Continuous Glucose Monitoring (CGM) System for people over the age of 18 with diabetes will launch in the United States on Dec. 1. At initial launch, Dexcom G7 15 Day will be available for users who receive their Dexcom CGM through DME providers. It will be covered for Medicare beneficiaries. "We’ve heard loud and clear from our users – they want more time with the Dexcom G7 because it gives them confidence, clarity and control over their health,” said Grant Ovzinsky, vice president of product management at Dexcom. “With 15.5 days of wear, we’re delivering on that ask. Fewer sensor changes mean less disruption, and more time benefiting from the most accurate CGM. It’s a meaningful step forward in empowering people with diabetes to live life on their terms.” With an overall mean absolute relative difference (MARD) of 8.0%, Dexcom says the G7 15 Day builds on the performance of Dexcom CGM, which is clinically proven to lower A1C, reduce hyper- and hypoglycemia, and increase time in range. To learn more about Dexcom G7 15 Day visit Dexcom.com/15day.
Comments